DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6BUDESONIDE
02 1DEXILANT
03 3DIMETHYL FUMARATE
04 1ENTOCORT EC
05 1ESOMEPRAZOLE MAGNESIUM
06 5FENOFIBRIC ACID
07 1OMEPRAZOLE MAGNESIUM
08 1ORTIKOS
09 1PANCREAZE
10 1PROCYSBI
01 121324
02 122287
03 122523
04 178878
05 190379
06 190410
07 1200750
08 1200913
09 1201573
10 1203389
11 1206134
12 1206200
13 1206623
14 1206724
15 1209339
16 1210305
17 1210309
18 1210499
19 1211626
20 1211929
21 1213450
01 18No
02 3Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206623
Country : US
Patented : No
Drug : DIMETHYL FUMARATE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 210499
Country : US
Patented : No
Drug : PROCYSBI
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 203389
Country : US
Patented : Yes
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206200
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 90410
Country : US
Patented : No
Drug : DIMETHYL FUMARATE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 210309
Country : US
Patented : No
Drug : FENOFIBRIC ACID
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 211626
Country : US
Patented : No
Drug : DEXILANT
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 22287
Country : US
Patented : Yes
PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)
Drug : PANCREAZE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 22523
Country : US
Patented : No
Drug : BUDESONIDE
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 206134
Country : US
Patented : No
